Accustem Sciences Inc.
ACUT
Revenue
0.00
0.000.00%
-Assets
139.66k
▲88.72k▲174.16%
3 Months ChangeLiabilities
3.02M
▲353.01k▲13.22%
3 Months ChangeFree Cash Flow
363.78k
▲363.78k∞%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-16
Form 10-Q
ID: 0001493152-24-036330
2024-05-20
Form 10-Q
ID: 0001493152-24-020584
2024-04-10
Form 8-K
ID: 0001493152-24-014171
2023-11-13
Form 10-Q
ID: 0001493152-23-040286
2023-08-14
Form 10-Q
ID: 0001493152-23-028164
2023-06-09
Form 8-K
ID: 0001493152-23-020727
2023-06-07
Form 8-K
ID: 0001493152-23-020328
2023-05-05
Form 10-Q
ID: 0001493152-23-015555
2022-11-16
Form 8-K
ID: 0001493152-22-032628
2022-11-08
Form 10-Q
ID: 0001493152-22-030905